CyberArk Software Gets Price Target Hikes By Analysts After Q1 Results

CyberArk Software Ltd (NASDAQ: CYBR) reported a narrower-than-expected loss for its first quarter.

CyberArk Software Ltd (NASDAQ:CYBR) reported a narrower-than-expected loss for its first quarter.

CyberArk Software reported first-quarter FY23 revenue growth of 27% year-on-year to $161.7 million, missing the consensus of $162.5 million. Non-GAAP EPS loss of $(0.17) beat the consensus loss of $(0.26).

CyberArk raised the non-GAAP EPS outlook to $0.16 – $0.38, up from $0.07 – $0.28 versus the consensus of $0.16.

CyberArk shares rose 3.9% to close at $142.71 on Thursday and lost 0.4% in after-hours trading.

These analysts made changes to their price targets on CyberArk following earnings announcement.

  • Needham raised the price target on CyberArk from $180 to $185. Needham analyst Alex Henderson maintained a Buy rating.
  • Barclays increased the price target on CyberArk from $175 to $178. Barclays analyst Saket Kalia maintained an Overweight rating
  • Rosenblatt analyst Catharine Trebnick, meanwhile, reiterated CyberArk Software with a Buy and maintained a $175 price target.

 

Read More: Investor Sentiment Declines Further After Dow Drops For Fourth Consecutive Day

Total
0
Shares
Related Posts
Read More

Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative To Improve Quality Of Care Through Identification, Dissemination, And Implementation Of Best Practices For The Diagnosis And Management Of Recur…

– Initiative aimed at improving access and outcomes for patients with recurrent pericarditis – – American Heart Association to work with champions at 15 healthcare sites to implement initiative activities and

KNSA